These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 27975250)

  • 41. Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.
    Wesseling H; Mair W; Kumar M; Schlaffner CN; Tang S; Beerepoot P; Fatou B; Guise AJ; Cheng L; Takeda S; Muntel J; Rotunno MS; Dujardin S; Davies P; Kosik KS; Miller BL; Berretta S; Hedreen JC; Grinberg LT; Seeley WW; Hyman BT; Steen H; Steen JA
    Cell; 2020 Dec; 183(6):1699-1713.e13. PubMed ID: 33188775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tau Lysine Pseudomethylation Regulates Microtubule Binding and Enhances Prion-like Tau Aggregation.
    Xia Y; Bell BM; Giasson BI
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Global Profiling of Lysine Accessibility to Evaluate Protein Structure Changes in Alzheimer's Disease.
    Yu K; Niu M; Wang H; Li Y; Wu Z; Zhang B; Haroutunian V; Peng J
    J Am Soc Mass Spectrom; 2021 Apr; 32(4):936-945. PubMed ID: 33683887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-Throughput Profiling of Proteome and Posttranslational Modifications by 16-Plex TMT Labeling and Mass Spectrometry.
    Yu K; Wang Z; Wu Z; Tan H; Mishra A; Peng J
    Methods Mol Biol; 2021; 2228():205-224. PubMed ID: 33950493
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery.
    Bai B; Vanderwall D; Li Y; Wang X; Poudel S; Wang H; Dey KK; Chen PC; Yang K; Peng J
    Mol Neurodegener; 2021 Aug; 16(1):55. PubMed ID: 34384464
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.
    Ando K; Dourlen P; Sambo AV; Bretteville A; Bélarbi K; Vingtdeux V; Eddarkaoui S; Drobecq H; Ghestem A; Bégard S; Demey-Thomas E; Melnyk P; Smet C; Lippens G; Maurage CA; Caillet-Boudin ML; Verdier Y; Vinh J; Landrieu I; Galas MC; Blum D; Hamdane M; Sergeant N; Buée L
    Neurobiol Aging; 2013 Mar; 34(3):757-69. PubMed ID: 22926167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lysine methylation is an endogenous post-translational modification of tau protein in human brain and a modulator of aggregation propensity.
    Funk KE; Thomas SN; Schafer KN; Cooper GL; Liao Z; Clark DJ; Yang AJ; Kuret J
    Biochem J; 2014 Aug; 462(1):77-88. PubMed ID: 24869773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of protein acetylation by mass spectrometry.
    Zee BM; Garcia BA
    Methods Mol Biol; 2013; 981():1-11. PubMed ID: 23381849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Charge neutralization of lysine via carbamylation reveals hidden aggregation hot-spots in tau protein flanking regions.
    Gadhavi J; Shah S; Sinha T; Jain A; Gupta S
    FEBS J; 2022 May; 289(9):2562-2577. PubMed ID: 34796642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alzheimer proteopathic tau seeds are biochemically a forme fruste of mature paired helical filaments.
    Kumar M; Quittot N; Dujardin S; Schlaffner CN; Viode A; Wiedmer A; Beerepoot P; Chun JE; Glynn C; Fernandes AR; Donahue C; Steen JA; Hyman BT
    Brain; 2024 Feb; 147(2):637-648. PubMed ID: 38236720
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comprehensive protocol to simultaneously study protein phosphorylation, acetylation, and N-linked sialylated glycosylation.
    Melo-Braga MN; Ibáñez-Vea M; Larsen MR; Kulej K
    Methods Mol Biol; 2015; 1295():275-92. PubMed ID: 25820729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
    Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
    OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of tau in cerebrospinal fluid using mass spectrometry.
    Portelius E; Hansson SF; Tran AJ; Zetterberg H; Grognet P; Vanmechelen E; Höglund K; Brinkmalm G; Westman-Brinkmalm A; Nordhoff E; Blennow K; Gobom J
    J Proteome Res; 2008 May; 7(5):2114-20. PubMed ID: 18351740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of Posttranslational Modifications (PTMs) of Proteins by Mass Spectrometry.
    Aslebagh R; Wormwood KL; Channaveerappa D; Wetie AGN; Woods AG; Darie CC
    Adv Exp Med Biol; 2019; 1140():199-224. PubMed ID: 31347049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proteomic Profiling and Functional Characterization of Multiple Post-Translational Modifications of Tubulin.
    Liu N; Xiong Y; Ren Y; Zhang L; He X; Wang X; Liu M; Li D; Shui W; Zhou J
    J Proteome Res; 2015 Aug; 14(8):3292-304. PubMed ID: 26165356
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of SAHA-Dependent Changes in Histone Modifications Using Data-Independent Acquisition Mass Spectrometry.
    Krautkramer KA; Reiter L; Denu JM; Dowell JA
    J Proteome Res; 2015 Aug; 14(8):3252-62. PubMed ID: 26120868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Global profiling of histone modifications in the polyomavirus BK virion minichromosome.
    Fang CY; Shen CH; Wang M; Chen PL; Chan MW; Hsu PH; Chang D
    Virology; 2015 Sep; 483():1-12. PubMed ID: 25958155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lysine-Directed Post-translational Modifications of Tau Protein in Alzheimer's Disease and Related Tauopathies.
    Kontaxi C; Piccardo P; Gill AC
    Front Mol Biosci; 2017; 4():56. PubMed ID: 28848737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-translational modifications and mass spectrometry detection.
    Silva AMN; Vitorino R; Domingues MRM; Spickett CM; Domingues P
    Free Radic Biol Med; 2013 Dec; 65():925-941. PubMed ID: 24002012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Post-Translational Modifications from Serum/Plasma by Immunoaffinity Enrichment and LC-MS/MS Analysis Without Depletion of Abundant Proteins.
    Gu H; Ren J; Jia X; Stokes MP
    Methods Mol Biol; 2017; 1619():119-125. PubMed ID: 28674881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.